Takotsubo Syndrome

5

Review clinical trials related to Takotsubo Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The GErman Italian Spanish Takotsubo (GEIST) Registry

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Prof. Dr. med. Ingo EitelUpdated: Dec 26, 2025Locations: 2Duration: 6 Months
Eligibility criteria

Patients with Takotsubo syndrome

Non

Status: Recruiting

Mechanisms And Prognosis of Stroke-Heart Syndrome

The incidence of stroke-heart syndrome following acute stroke, which encompasses both acute ischemic stroke and acute intracerebral hemorrhage, is notably high and is strongly associated with increased mortality and poor outcomes in stroke patients. However, the underlying mechanisms remain unclear, and there are currently no effective prevention or treatment strategies. This study aims to elucidate the neuro-humoral mechanisms of stroke-heart syndrome through multimodal imaging and multi-omics blood analysis. Additionally, it seeks to observe the progression of stroke-heart syndrome and its impact on functional outcomes, cognitive abilities, and emotional issues post-stroke. The research is expected to uncover novel blood biomarkers and brain network mechanisms associated with stroke-heart syndrome, providing potential targets and theoretical foundations for pharmacological treatments or physical interventions. Furthermore, it aims to establish a risk early-warning system for major cardiovascular complications post-stroke, enabling early identification, early intervention, and integrated brain-heart management to improve clinical outcomes for stroke patients.

Participants needed: 658
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chensheng PanUpdated: May 1, 2025Locations: 1
Eligibility criteria

Patients admitted within 48 hours of onset, confirmed by CT/MRI as having a stro... [+1]

Previous focal brain injury (such as stroke, brain surgery, traumatic brain inju... [+6]

Status: Recruiting

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

The aim of this study is to document an optimized pharmacologic treatment for patients with Takotsubo Syndrome. There is currently no published documentation in a large number of patients. The study is a Randomized Registry Clinical Trial and in total 1000 patients registered in SWEDEHEART will be included.

Participants needed: 1,000
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Vastra Gotaland RegionUpdated: Dec 2, 2024Locations: 16
Eligibility criteria

Age ≥ 18 years. [+2]

Previous randomization in the trial [+18]

Status: Recruiting

Takotsubo Syndrome and Air Pollution

Takotsubo syndrome (TTS) is an acute and reversible form of myocardial injury characterized by typical regional wall motion abnormalities in the absence of culprit epicardial coronary artery disease frequently precipitated by significant emotional stress or serious physical illness. The clinical presentation is usually similar to acute myocardial infarction (MI), with chest pain and/or dyspnea, ST-segment elevation or depression and/or T-wave inversion on the resting electrocardiogram (ECG) and elevation of serum cardiac troponin. Although previously considered a benign disease, it is now clear that TTS is associated with severe acute complications during the acute phase including hemodynamic and electrical instability and up to 5% of in-hospital mortality. The pathogenetic mechanisms of air pollution are likely to predispose to the occurrence as well as to mediate a worse clinical presentation and outcome of TTS, proving air pollution as a TTS risk factor.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSUpdated: Feb 26, 2024Locations: 1
Eligibility criteria

Age ≥18 years. [+3]

Age <18 years. [+1]

Status: Recruiting

Polish Registry of Takotsubo Syndrome

Polish registry of takotsubo syndrome

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Medical University of WarsawUpdated: Nov 18, 2020Locations: 1Duration: 10 Years
Eligibility criteria

Not listed